A Dyadic Approach to Cancer Care: a Feasibility and Efficacy Partner-based Exercise Study (C4C)

February 11, 2025 updated by: Melanie Keats, Nova Scotia Health Authority
The primary goal of this study will be to assess the feasibility and acceptability of a partner-based 12-week exercise intervention for cancer caregivers and their care recipient. The researchers will also explore the preliminary effectiveness of the exercise program on caregiver burden and physical and psychological health of both the family caregiver and the care recipient.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

NEED: Cancer has been characterized as a family affair, as it is a disease in which both the patient and their family members are confronted by considerable physical and psychological stressors. With an anticipated 80% increase in the average number of new cancer diagnoses by 2030 and rapidly escalating health care costs, there has been a shift to outpatient and home-based care. In doing so, family members are increasingly being called upon to participate as informal caregivers (i.e., an individual who provided uncompensated care). Despite being a key partner in the supportive care of the cancer patient, family caregivers are often inadequately prepared or supported to take on this critical role, subsequently putting their own health and well-being at risk and by extension, that of the cancer patient/survivor. Preliminary data suggests that exercise interventions show promise in mitigating caregiver burden and improving health outcomes for both the caregiver and the patient/survivor. To date, however only two studies have examined the benefit of exercise interventions on family caregiver and patient outcomes within the cancer care context.

GOAL: The primary goal of this study will be to assess the feasibility and acceptability of a partner-based 12-week exercise intervention. The investigators will also explore the preliminary effectiveness of the exercise program on caregiver burden and physical and psychological health of both the family caregiver and the care recipient.

WHO: Participants will include adult primary caregivers and cancer patients/survivors of all cancers and stages at any point along the cancer care trajectory.

HOW: Using both surveys and participant interviews, the participant experience and impact (e.g., physical and psychological health benefits) of a 12-week, partner-based exercise intervention will be evaluated. The 12-week exercise program will include a combination of aerobic, resistance, balance, and flexibility exercises delivered in a partner-based setting twice weekly at a dedicated cancer and exercise lab.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 2Y9
        • Physical Activity and Cancer (PAC) Lab

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria (all):

  • 18+ years
  • able to perform discontinuous low intensity physical activity at a minimum
  • able to provide informed written consent in English.

Inclusion Criteria (cancer patients/survivors)

- are along any stage of the cancer continuum (i.e., pre-treatment, receiving active treatment, and up to 5 years post-treatment)

Inclusion Criteria (informal caregivers)

  • must be currently providing physical and/or psychological support to an adult (+18 years) cancer patient/survivor
  • not be exceeding current Canadian physical activity guidelines (i.e., 150 minutes of moderate-to-vigorous physical activity per week)

Exclusion Criteria (all):

- Patients/survivors and caregivers will be excluded from the study if they have any medical conditions that would contraindicate exercise

Exclusion Criteria (informal caregivers)

- Bereaved caregivers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multimodal Exercise Intervention
12-week, twice weekly partner-based multimodal exercise program
Multimodal exercise programming including aerobic, resistance, balance, and flexibility exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment
Time Frame: Through study completion, about 2 years
Participant accrual as defined as the number of eligible participant dyads who consents to participate
Through study completion, about 2 years
Intervention Adherence
Time Frame: Through study completion, about 2 years
Participant program adherence calculated as percentage of exercise sessions completed divided by total number of available exercise sessions over 12-week intervention
Through study completion, about 2 years
Adverse Events
Time Frame: Through study completion, about 2 years
Adverse and serious adverse events will be recorded
Through study completion, about 2 years
Attrition
Time Frame: Through study completion, about 2 years
Participant attrition calculated as percentage of patients who complete 12-week study divided by number who withdraw from study
Through study completion, about 2 years
Participant Satisfaction
Time Frame: Post intervention, about 12-weeks after baseline
Participant satisfaction will be assessed by semi-structured interviews (no min/max)
Post intervention, about 12-weeks after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver Burden
Time Frame: Pre to post intervention (12-week change)
Assessed by the 22-item Zarit Burden Interview (ZBI). Responses are scored on a 5-point Likert scale ranging from 0 (never) to 4 (nearly always) with the sum of scores ranging from 0 to 88 (higher scores indicate higher burden)
Pre to post intervention (12-week change)
Body Mass Index (BMI)
Time Frame: Pre to post intervention (12-week change)
Weight (kg) and height (m) will be used to calculate BMI
Pre to post intervention (12-week change)
Body Composition
Time Frame: Pre to post intervention (12-week change)
Waist and hip circumference
Pre to post intervention (12-week change)
Resting heart rate
Time Frame: Pre to post intervention (12-week change)
Resting heart rate
Pre to post intervention (12-week change)
Resting Blood Pressure
Time Frame: Pre to post intervention (12-week change)
Resting systolic and diastolic blood pressure
Pre to post intervention (12-week change)
Aerobic Fitness
Time Frame: Pre to post intervention (12-week change)
The 6-minute walk test will be used to assess aerobic capacity
Pre to post intervention (12-week change)
Upper Body Strength
Time Frame: Pre to post intervention (12-week change)
Grip strength will be measured using a hand-held dynamometer
Pre to post intervention (12-week change)
Muscular Endurance
Time Frame: Pre to post intervention (12-week change)
Lower body muscular endurance will be assessed using the 30-second sit-to-stand
Pre to post intervention (12-week change)
Balance
Time Frame: Pre to post intervention (12-week change)
Balance will be assessed using the one-legged stance
Pre to post intervention (12-week change)
Flexibility
Time Frame: Pre to post intervention (12-week change)
Flexibility will be assessed using the sit-and-reach and shoulder flexibility
Pre to post intervention (12-week change)
Caregiver Quality of Life
Time Frame: Pre to post intervention (12-week change)
Quality of life will be assessed using the Short-Form Health Survey- SF-36. The SF-36 consists of 36 questions that cover 8 health domains/subscales (physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health). The total scale score ranges from 0 to 100 with higher values representing higher quality of life.
Pre to post intervention (12-week change)
Cancer Patient Quality of Life
Time Frame: Pre to post intervention (12-week change)
Quality of life for cancer patients will be assessed using the Functional Assessment of Cancer Therapy - General survey. The combined 27-item scale provides subscale scores physical (7-items), functional (7-items), emotional (6-items), and social/family (7-items) well-being. The sum of scores on the five domains evaluates a participants' quality of life with higher scores (ranging from 0-108) denoting higher quality of life.
Pre to post intervention (12-week change)
Cancer Patient Fatigue
Time Frame: Pre to post intervention (12-week change)
Fatigue will be assessed using the 13-item Functional Assessment of Chronic Illness Therapy - Fatigue survey. Scores range from 0-52 with higher scores indicating better functioning/less fatigue
Pre to post intervention (12-week change)
Self-Reported Physical Activity
Time Frame: Pre to post intervention (12-week change)
Physical activity will be assessed using the Godin Leisure Time Exercise Questionnaire. Total score ranges from 0 to no maximum.
Pre to post intervention (12-week change)
General Health (EuroQol) 5 Dimension - 5 Level
Time Frame: Pre to post intervention (12-week change)
Mobility, self-care, usual activities, pain/discomfort, anxiety/depression (EuroQol-5Dimension-5Level; EQ-5D-5L); higher scores indicate higher problems (range 0-1)
Pre to post intervention (12-week change)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melanie Keats, PhD, Dalhousie University / Nova Scotia Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2023

Primary Completion (Actual)

December 31, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

April 4, 2022

First Submitted That Met QC Criteria

April 11, 2022

First Posted (Actual)

April 18, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 11, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NSH Caring 4 Cancer Caregivers

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Multimodal exercise

Subscribe